Study Summary
To observe the efficacy and safety of CD7-targeted chimeric antigen receptor T cells in the treatment of T-lymphoblastic leukaemia/lymphoma with postive measurable residual disease positive post allogeneic stem cell transplantation
Want to learn more about this trial?
Request More InfoInterventions
CAR-T TherapyDRUG
autologous or donor-derived CD7-targeted CAR-T cells, single injection
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Peking University People's Hospital | Beijing | China | China |